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Carotid Stiffness in Young Adults: A Life-Course Analysis
of its Early Determinants
The Amsterdam Growth and Health Longitudinal Study
Isabel Ferreira, Roel J. van de Laar, Martin H. Prins, Jos W. Twisk, Coen D. Stehouwer
Abstract—Cardiovascular risk factors affecting arterial stiffness in adulthood may develop at different critical periods
earlier in life. We examined whether the trajectories, from adolescence to young adulthood, of blood pressure, body
fatness and fat distribution, blood lipids, cardiorespiratory fitness, and heart rate determined levels of arterial stiffness
in young adults. We investigated 373 apparently healthy adults in whom cardiovascular risk factors were repeatedly
examined between the ages of 13 and 36 years and carotid stiffness estimates were obtained at the age of 36 years.
Differences in the mean levels and the trajectories of risk factors throughout the 24-year longitudinal period between
subjects with different levels of carotid stiffness at age 36 years were analyzed with generalized estimating equations.
Compared with individuals with less stiff carotid arteries, those with stiffer carotid arteries at the age of 36 years were
characterized from ages 13 to 36 years by greater levels of and steeper increases in blood pressure and central fatness,
independently of each other and other risk factors. These increases were already present in adolescence, preceded the
development of poorer levels of blood lipids, cardiorespiratory fitness, and heart rate, which were evident during
adulthood only, and explained to a great extent the deleterious association between these risk factors and carotid stiffness
at the age of 36 years. Multiple and intertwined mechanisms involved in the pathogenesis of arterial stiffness have their
origins in early life. Blood pressure and central fatness have a pivotal role herein and should be specifically targeted to
prevent arterial stiffening and its cardiovascular sequelae. (Hypertension. 2012;59:54-61.) ● Online Data Supplement
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Arterial stiffness is an important cause of cardiovasculardisease because of its contribution to systolic hyperten-
sion, left ventricular hypertrophy, and impaired coronary
perfusion.1–3 Arterial stiffness is primarily determined by
aging and mean arterial pressure (MAP),2,4 but other risk
factors (RF) may also contribute, notably body fatness and/or
a central pattern of fat distribution,5–8 impaired glucose
metabolism and insulin resistance,2 poor cardiorespiratory
fitness,9,10 and dyslipidemia.11,12 Recently, a systematic re-
view suggested that the contribution to arterial stiffness of RF
other than blood pressure (BP) was only modest, although
this evidence was derived from cross-sectional studies only.13
Therefore, a life-course rather than a single time-point ap-
proach to the study of (early) determinants of arterial stiffness
is needed.
The negligible, if any, role of RF other than BP on arterial
stiffness was also emphasized in a prospective analysis
conducted among men throughout middle age and older
age.14 However, some evidence suggests that arterial stiffness
in adulthood has its roots early in life. Indeed, studies among
the young have shown that greater levels of BP15,16 and body
fatness and/or a central pattern of fat distribution5,15,17 mea-
sured in childhood/adolescence were associated with greater
arterial stiffness in adulthood. However, how the life-course
trajectories and cumulative burden of these, and also of other
RF such as dyslipidemia, cardiorespiratory fitness, and rest-
ing heart rate (HR), which are all intertwined, affect arterial
stiffness later in life is not known. For instance, RF affecting
arterial stiffness in adulthood may develop at different critical
or sensitive periods earlier in life.18 In addition, elevations in
some RF occurring early in life may accelerate over time and
trigger the development of other RF, all of which may impact
adversely on arterial stiffness later in life. From a preventive
point of view, identifying such critical periods and triggering
RF early in life is of utmost importance to inform targeted
interventions with the most potential for health benefits by
breaking chains of risk and enabling establishment of health-
ier life-course trajectories.18
To address these issues, we have therefore investigated in
the Amsterdam Growth and Health Longitudinal Study
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(AGAHLS) the extent to which the life-course trajectories
and their inter-(in)dependent associations, from ages 13 to 36
years, of blood pressure, body fatness and fat distribution,
blood lipids, cardiorespiratory fitness, and resting HR deter-
mined the levels of carotid artery stiffness at age 36 years.
Subjects and Methods
Subjects and Study Design
The AGAHLS is an observational longitudinal study that started in 1977
with a group of600 boys and girls from 2 secondary schools from the
area of Amsterdam (The Netherlands). Its initial goal was to describe the
natural development of growth, health, and lifestyle of adolescents, and
to investigate longitudinal relationships between biological and lifestyle
RF, as described in detail elsewhere.19 The mean age of the subjects at
the beginning of the study was 13.10.8 years. Since then, measure-
ments have been obtained 2 to 8 times (up to the age of 36 years) during
a 24-year follow-up period. At each measurement round, anthropometri-
cal (body height, weight, and skinfolds [SKF]), biological (serum
lipoprotein levels, BP, cardiorespiratory fitness, and HR), and lifestyle
(nutritional habits, smoking behavior, daily physical activity) RF were
assessed according to standard procedures19–22 (http://hyper.ahajournals.
org). In the year 2000, when the subjects’ mean ages were 36.50.6
years, large artery properties were assessed for the first time in 373 (196
women) subjects according to guidelines for user procedures and with
the use of reproducible and valid methods and devices.1 The following
carotid stiffness estimates were calculated: the distensibility coefficient
(DC), the compliance coefficient (CC), and the Young’s elastic modulus
as described in detail elsewhere5,8,21,23 (http://hyper.ahajournals.org).
The study was approved by the medical ethical committee of the
VU University Medical Center (Amsterdam, The Netherlands). All
subjects gave their written informed consent (provided by their
parents when subjects were 13–16 years old).
Statistical Analyses
We used generalized estimating equations24 to compare the trajec-
tories and the mean levels of systolic pressure (SP), diastolic
pressure (DP), and MAP, body fatness (ie, the body mass index
[BMI], sum of 4 SKF) and fat distribution (SKF ratio), blood lipids
(total-to-high-density lipoprotein [HDL] cholesterol, triglycerides),
and physical fitness (cardiorespiratory fitnessVO2max, resting HR)
between subjects with increasing levels of carotid stiffness at the age
of 36 years. Subjects were grouped according to sex-specific tertiles
(T) of each carotid stiffness estimate.
Adopting generalized estimating equations as method for data
analyses allowed us to use all data available from the age of 13 to 36
years, properly adjusting for the correlation between repeated obser-
vations of the same subject and handling data from subjects with
varying number and unequally time-spaced observations.22,24 All
analyses were first adjusted for sex, body height (to account for the
subject’s growth), and time (modeled as a categorical variable to
allow departures from linearity; model 1). This model thus reflects
the cumulative burden of each RF on adult carotid stiffness.
Subsequently, we compared the life-course trajectories of each RF
between groups with increasing gradients of carotid stiffness by
adding interaction terms between group and time; results obtained
were displayed graphically (smoothed line plots).20,21 These analyses
enable us to pinpoint the exact moment early in life when differences
in RF between groups emerged. To analyze the extent to which the
concomitant life-course of other RF explained any of the differences
found between groups, analyses were further adjusted for potential
confounders (ie, lifestyle variables [model 2]) and/or mediators (ie,
sitting MAP, [central] body fatness, blood lipids, and physical fitness
[models 3A–E]). Finally, all analyses were also adjusted for the
levels of MAP at which stiffness estimates were estimated (ie,
current MAPsupine [model 4]). Because MAPsupine is highly corre-
lated with sitting MAP at age 36 years, which reflects attained levels
of MAP at the end of the longitudinal period, this adjustment meant,
for a great portion, removal of the effects of BP tracking.
In all generalized estimating equations analyses, an exchangeable
correlation structure was used, which was deemed as the most
parsimonious after examination of the interperiod correlation ma-
trixes of the cardiovascular RF throughout the 24-year study period.
All results are reported for men and women combined because no
significant interactions with sex were found. Triglycerides levels,
which were positively skewed, were log-transformed before all
analyses.
Statistical significance was set at P0.05. All analyses were
performed with the use of the STATA software package version 11
(STATA Corp, College Station, TX).
Results
From the lowest (T1) to the highest tertiles (T3), subjects’
meanSD levels of the carotid DC (in 103/kPa) were
20.32.2, 26.21.6, and 33.44.1, of the carotid CC
(in mm2/kPa) were 0.720.12, 0.970.09, 1.280.20, and
of the carotid Young’s elastic modulus (in 103k˙Pa) were
0.320.05, 0.430.03, and 0.580.09 (P for linear trend
0.001 for all). Differences in the carotid DC and CC
between subjects in the highest vs lowest tertiles were
equivalent to values observed in the course of one decade of
aging;25 groups herein defined as having stiffer arteries (ie, in
T1 for DC and CC or in T3 for Young’s elastic modulus) and
less stiff arteries (in T3 for DC and CC or in T1 for Young’s
elastic modulus) translate into potentially clinical relevant
differences in carotid stiffness levels.
Table 1 shows the general characteristics of the study popu-
lation throughout the longitudinal period stratified by levels of
subjects’ carotid DC at age 36 years. All data shown are those of
groups defined on the basis of this stiffness estimate; qualita-
tively similar findings were found when groups were defined on
the basis of the carotid CC or Young’s elastic modulus instead
(Supplemental Table S1, http://hyper.ahajournals.org).
Trajectories and Cumulative Burden of
Blood Pressure
Subjects with stiffer arteries (ie, in T1 of the carotid DC) had
on average and throughout the whole longitudinal period
(in mm Hg [95% CI]) 5.3 (3.9–6.8), 4.7 (2.6–6.8), and 5.7
(4.3–7.1) greater levels of MAP, SP, and DP, respectively,
than those with less stiff arteries (T3; Table 2, model 1).
Importantly, these differences were not constant over time,
and although being already present during adolescence (eg, at
age 14 years: 3.5 [1.5–5.5] for MAP, 2.6 [0.1–5.1] for SP, and
4.0 [1.6–6.3] for DP), were further amplified from this age
onward and more strongly so in subjects with stiffer arteries
(rate of BP increase, in mm Hg/year [95% CI]: 0.51 [0.43–
0.59] for MAP, 0.31 [0.21–0.40] for SP, and 0.61 [0.52–
0.70] for DP) than with less stiff arteries (0.28 [0.20–0.37]
for MAP, 0.02 [0.08–0.13] for SP, and 0.41 [0.32–0.51]
for DP; Figure A–C). These steeper increases in BP resulted
in differences between the 2 groups that were 2.5-fold
greater at age 36 years (9.0 [6.5–11.4], 8.7 [5.5–11.8], and 9.1
[6.7–11.6], for MAP, SP, and DP, respectively) vs age 14
years. Adjustment for lifestyle variables did not materially
change the mean differences over time between groups
(model 2), and further adjustment for other RF attenuated the
differences in BP, mainly because of central fatness (model
3B), which nevertheless remained significant. Further adjust-
ment for current MAPsupine attenuated the differences in BP
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Table 1. Characteristics of the Study Population (n373)* Throughout the 24-Year Longitudinal Period by Levels of Carotid
Stiffness at Age 36 Years
Characteristics Group
Age (y)
13 14 15 16 21 27 32 36
Blood pressure
Mean arterial
pressure, mm Hg
T1 92.76.6 92.56.0 90.56.0 93.36.2 96.18.3 98.68.5 102.29.8 105.010.6
T2 91.37.6 91.77.5 90.07.6 91.57.8 95.88.8 97.68.7 99.08.4 100.010.2
T3 91.46.6 90.55.8 89.56.2 89.57.3 93.56.1 94.37.2 97.78.2 97.010.9
Systolic pressure, mm Hg T1 124.88.7 123.28.8 125.09.5 126.69.5 128.911.0 130.211.6 131.412.9 135.413.4
T2 124.59.5 123.39.3 125.110.3 125.511.6 129.312.6 129.412.6 128.712.0 130.013.7
T3 124.710.0 123.59.8 125.410.1 125.610.9 127.99.9 128.211.5 128.912.3 128.315.0
Diastolic pressure, mm Hg T1 76.77.3 77.27.0 73.37.8 76.67.0 79.78.6 82.88.7 87.69.4 89.810.5
T2 74.88.7 75.98.6 72.49.1 74.58.2 79.19.4 81.78.6 84.28.1 85.29.4
T3 74.87.2 73.96.3 71.66.9 71.48.6 76.35.7 77.47.2 82.28.0 81.310.2
Prehypertension/
hypertension, %
T1 2.5/2.5 25.8/11.3 22.6/22.6 25.9/34.8 32.3/37.9
T2 3.3/3.3 20.8/18.8 23.5/17.6 32.2/19.1 29.6/22.4
T3 2.5/2.5 25.7/5.7 19.4/13.9 20.8/20.0 27.4/13.7
Body fatness/fat distribution
Body mass index, kg/m2 T1 18.02.1 18.52.3 19.42.4 20.12.5 21.52.5 22.52.7 24.03.3 24.93.6
T2 17.61.6 18.21.8 19.01.8 19.61.7 21.21.9 22.21.9 23.32.7 23.92.7
T3 17.51.7 18.72.0 19.31.9 19.81.7 21.42.1 21.92.2 22.82.7 23.52.9
Overweight/obesity, % T1 4.1/0 8.1/0 19.4/0 29.5/3.6 37.1/8.9
T2 0.8/0 2.1/0 9.8/0 18.0/1.7 28.8/1.6
T3 2.5/0 2.9/0 8.3/0 10.0/2.5 21.8/3.2
Sum of 4 skinfolds, mm† T1 33.914.3 33.915.1 37.016.8 40.919.6 47.219.4 46.018.9 52.521.8 56.619.5
T2 31.110.9 33.013.2 33.613.6 37.814.3 43.214.4 40.613.9 46.517.7 50.016.1
T3 30.89.7 33.513.7 35.214.2 37.113.7 42.716.7 36.511.7 43.317.0 48.017.7
Skinfold ratio‡ T1 0.500.06 0.520.05 0.540.06 0.550.06 0.580.07 0.570.09 0.570.09 0.590.10
T2 0.490.06 0.510.06 0.530.06 0.540.06 0.570.07 0.560.08 0.570.09 0.570.10
T3 0.480.06 0.500.06 0.520.06 0.540.06 0.570.09 0.560.09 0.550.09 0.550.10
Blood lipids
Total-to-high-density
lipoprotein cholesterol ratio
T1 3.10.7 3.10.6 3.30.6 3.10.7 3.70.8 3.71.0 3.81.2 4.11.4
T2 3.20.7 3.20.7 3.50.8 3.40.8 3.80.8 3.90.9 3.81.2 3.91.3
T3 3.10.7 3.10.7 3.40.9 3.20.7 3.81.1 3.71.3 3.51.1 3.51.2
Triglycerides, mmol/L T1 . . . . . . . . . . . . 0.8 (0.5–1.2) 0.8 (0.7–1.2) 1.0 (0.7–1.4) 1.2 (0.8–1.6)
T2 . . . . . . . . . . . . 0.8 (0.6–1.1) 1.1 (0.9–1.4) 1.0 (0.7–1.3) 1.1 (0.8–1.6)
T3 . . . . . . . . . . . . 0.7 (0.5–1.0) 0.8 (0.7–1.1) 0.9 (0.7–1.2) 0.9 (0.7–1.2)
Physical fitness
VO2max, mL/min per kg
FFM T1 68.96.7 68.65.8 66.46.5 65.96.6 59.56.6 55.86.1 55.47.2 60.18.2
T2 70.36.6 68.76.4 67.65.1 66.36.3 60.95.7 56.96.1 56.68.0 59.68.7
T3 69.36.1 69.46.7 67.25.2 66.46.9 58.96.2 57.47.2 57.26.9 61.98.2
Resting heart rate, bpm T1 85.414.7 80.913.7 81.115.3 77.514.5 74.414.8 76.412.9 79.013.7 74.411.5
T2 81.914.1 79.613.6 77.515.5 75.412.7 71.811.7 70.211.8 74.513.5 69.79.4
T3 82.914.0 77.212.3 76.412.5 73.914.4 69.512.5 67.512.0 72.813.8 69.411.2
Lifestyle
Total energy intake, 103
kcal/d
T1 2.470.54 2.460.59 2.500.61 2.470.68 2.500.71 2.310.55 2.470.64 2.540.60
T2 2.440.56 2.490.54 2.640.66 2.600.64 2.670.73 2.540.64 2.570.72 2.590.73
T3 2.480.54 2.610.64 2.640.77 2.600.75 2.760.76 2.670.73 2.750.74 2.740.74
Total physical activity, 103
metabolic equivalent/wk
T1 4.431.96 4.151.67 3.731.73 3.501.74 3.202.24 2.942.07 3.312.45 4.582.79
T2 4.441.90 3.751.54 3.771.60 3.451.36 3.321.91 3.362.24 3.432.48 4.873.24
T3 4.381.56 4.111.64 3.601.49 3.621.51 3.382.06 2.611.47 3.501.96 5.193.70
(Continued)
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between groups considerably, although the differences in
MAP and DP remained statistically significant (model 4).
Trajectories and Cumulative Burden of Fatness
and Fat Distribution
Subjects with stiffer arteries at age 36 years had greater mean
levels of BMI (1.06 kg/m2; 95% CI, 0.47–1.65), sum of 4
SKF (SKF, 6.1 mm; 95% CI, 2.9–9.4), and SKF ratio (*10;
0.36; 95% CI, 0.22–0.51) over the whole longitudinal period,
as compared with those with less stiff arteries (Table 2, model
1). Subjects with stiffer arteries also had steeper increases in
these estimates from adolescence to age 36 years (Figure
D–F). For instance, BMI levels differed significantly from
those with less stiff arteries already at age 15 years (0.71
kg/m2; 95% CI, 0.04–1.39), and this difference was approx-
imately twice as much at age 36 years (1.59 kg/m2; 95% CI,
0.76–2.42). Similarly, the differences in SKF ratio (*10),
which were already present at age 13 years (0.26; 95% CI,
0.08–0.43) increased even more thereafter, being 2-fold
greater at age 36 years (0.46; 95% CI, 0.28–0.65). Adjust-
ments for lifestyle variables did not materially change the
mean differences over time between groups (model 2), but
further adjustment for other RF (model 3), particularly MAP
(model 3A) and total-to-HDL cholesterol ratio (model 3B),
attenuated the differences in BMI and SKF considerably.
Noteworthy, the differences in the SKF ratio were affected to
a lesser extent by these adjustments (models 3) and remained
significant, even when these included current MAPsupine
(model 4).
Trajectories and Cumulative Burden of Blood
Lipids and Physical Fitness
Subjects with stiffer arteries, as compared with those with
less stiff arteries, had on average 0.37 (95% CI, 0.15–0.56)
Table 1. Continued
Characteristics Group
Age (y)
13 14 15 16 21 27 32 36
Smoking, % T1 3.4 10.8 10.7 25.3 31.1 19.4 20.5 21.8
T2 1.2 10.7 16.4 9.1 20.8 25.5 21.4 24.2
T3 0.0 11.8 15.3 17.8 40.0 38.9 18.8 24.4
Alcohol consumption, % T1 16.3 18.9 36.0 50.6 71.0 74.2 83.2 81.8
T2 13.4 18.4 39.2 50.0 66.7 72.5 77.4 82.9
T3 10.1 7.8 22.4 41.7 68.6 69.4 80.5 81.5
Data are meansSD or percentages or median (interquartile range).
For metabolic equivalents, 1 metabolic equivalent represents the energy expended in 1 min by a person at rest.
*Exact n differs at each time point and per variable because of missing observations.
†Biceps, triceps, subscapular and suprailiac.
‡The ratio of the subscapularsuprailiac to the bicepstricepssubscapularsuprailiac skinfolds.
Tertiles (T) represent groups with increasing levels of the carotid distensibility coefficient at age 36 years: T1, with stiffer arteries; T2, with intermediate stiff arteries;
T3, with less stiff arteries. FFM indicates free fat mass.
Table 2. Mean Differences in Blood Pressure and Body Fatness Throughout the 24-Year Longitudinal Period Between Subjects With
Stiffer vs Less Stiff Carotid Arteries at Age of 36 Years
Model Adjustments
Mean Arterial
Pressure
(mm Hg)
Systolic Pressure
(mm Hg)
Diastolic
Pressure
(mm Hg)
Body Mass Index
(kg/m2)
Sum of 4
Skinfolds (mm) Skinfold Ratio (*10)
 95% CI  95% CI  95% CI  95% CI  95% CI  95% CI
1 Sex, height and time 5.3‡ 3.9; 6.8 4.7‡ 2.6; 6.8 5.7‡ 4.3; 7.1 1.06‡ 0.47; 1.65 6.1‡ 2.9; 9.4 0.36‡ 0.22; 0.51
2 Model 1lifestyle variables§ 5.2‡ 3.7; 6.6 4.5‡ 2.4; 6.6 5.5‡ 4.1; 6.9 1.08† 0.46; 1.70 6.2‡ 2.9; 9.6 0.34‡ 0.20; 0.49
3A Model 2mean arterial
pressure
. . . . . . . . . . . . . . . . . . 0.70* 0.10; 1.30 3.9* 0.7; 7.2 0.28‡ 0.14; 0.43
3B Model 2skinfolds ratio 4.6‡ 3.1; 6.0 3.7† 1.6; 5.8 5.0‡ 3.6; 6.5 . . . . . . . . . . . . . . . . . .
3C Model 2total-to-hihg-density
lipoprotein cholesterol ratio
4.7‡ 3.2; 6.1 4.0‡ 1.9; 6.1 5.1‡ 3.7; 6.4 0.77* 0.18; 1.36 4.3† 1.1; 7.5 0.27‡ 0.14; 0.41
3D Model 2VO2max 5.1‡ 3.7; 6.6 4.5‡ 2.4; 6.5 5.5‡ 4.1; 6.8 1.02† 0.41; 1.63 5.9† 2.6; 9.2 0.34‡ 0.20; 0.48
3E Model 2resting heart rate 4.9‡ 3.5; 6.3 4.1‡ 2.1; 6.2 5.3‡ 3.9; 6.6 1.05† 0.43; 1.67 5.8† 2.5; 9.1 0.34‡ 0.20; 0.49
3 Model 2all risk factors in
models 3A–E
4.1‡ 2.6; 5.5 3.0† 0.9; 5.1 4.6‡ 3.2; 6.0 0.46 0.11; 1.03 2.4 0.7; 5.5 0.25‡ 0.11; 0.38
4 Model 3current MAPsupine 1.7* 0.3; 3.1 0.0 2.2; 2.2 2.6‡ 1.2; 3.9 0.19 0.42; 0.80 1.1 2.1; 4.2 0.29‡ 0.15; 0.43
 values are longitudinal regression coefficients and indicate mean differences over time between subjects with stiffer (lowest tertile) vs less stiff (highest tertile
of the carotid distensibility coefficient) for each risk factor listed in column headings. Each row indicates such differences after successive adjustments for the
(longitudinal) levels of the variables specified by each model.
*P0.05; †P0.01; ‡P0.001.
§Total energy intake, physical activity, smoking, and alcohol consumption status.
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Figure. Comparison of the life-course trajectories of potential determinants of arterial stiffness between subjects with stiffer (ie, lowest tertile
[T1]) vs less stiff carotid arteries (highest tertile [T3]) at age 36 years: (A) mean arterial pressure (MAP); (B) systolic pressure (SP); (C) diastolic
pressure (DP); (D) body mass index (BMI); (E) sum of four skinfolds (SKF); (F) SKF ratio; (G) total-to-high-density lipoprotein (HDL) cholester-
ol ratio; (H) triglycerides; (I) cardiopulmonary fitness (VO2max); and (J) resting heart rate (HR). Lines for the middle tertile (T2) indicate patterns
for subjects with intermediate levels of carotid stiffness. All data are adjusted for sex and height; values for triglycerides are geometric means.
*P0.05, †P0.01, and ‡P0.001 for comparisons between subjects with stiffer vs less stiff carotid arteries.
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greater levels of total-to-HDL cholesterol ratio and 1.08-
times (95% CI, 1.03–1.12) greater levels of triglycerides
throughout the longitudinal period. The differences in total-
to-HDL cholesterol ratio emerged after adolescence only,
becoming significant from the age of 27 years onward (Figure
G); the differences in triglycerides, which were assessed
during young adulthood only, were present at ages 32 and 36
years (Figure H). The mean differences over time in both
total-to-HDL cholesterol and triglycerides were independent
of lifestyle variables (model 2) but were greatly reduced
after adjustments for other risk factors, particularly MAP and the
SKF ratio (models 3A and 3B; Supplemental Table S2;
http://hyper.ahajournals.org).
Subjects with stiffer arteries, as compared with those with
less stiff arteries, had on average 1.39 mL/min/kgFFM (95%
CI, 2.58 to 0.19) lower levels of VO2max and 4.7 bpm
(95% CI, 2.3–7.1) higher levels of HR throughout the whole
longitudinal period. Although VO2max and HR decreased
from adolescence to age 36 years in all subjects, these
trajectories were more adverse in individuals with stiffer
arteries. However, significant differences between groups
were only observed during adulthood (at age 27 years and
onward for VO2max, Figure I; and at age 21 years and onward
for HR, Figure J). Mean differences over time between
groups were only slightly attenuated after adjustments for
lifestyle RF (model 2), but more markedly so after further
adjustments for the other RF (model 3; Supplemental Table
S2; http://hyper.ahajournals.org).
Discussion
We investigated the trajectories, from adolescence to adult-
hood, of potential determinants of carotid stiffness. We show
that as compared with individuals with less stiff arteries at age
36 years, those with stiffer arteries were characterized, from
ages 13 to 36 years, by greater levels of and steeper increases
in BP and central fatness, independently of each other and of
other RF. These increases were already present in adoles-
cence, preceded the development of poorer levels of blood
lipids, cardiorespiratory fitness, and heart rate, which were
evident during adulthood only, and explained, to great extent,
the deleterious association between these RF and carotid
stiffness at age 36 years. This is the first study to investigate
and tease apart the relative role of several potential determi-
nants of arterial stiffness with a longitudinal design. Our
findings support the view of adolescence as a critical period
for the development of elevated BP, mainly DP, and (central)
fatness and its associated cardiovascular morbidities later in
life.26–28
In agreement with previous observations,15–17 we show that
subjects with stiffer arteries in adulthood were characterized
by greater levels of BP early in life. Given the great
dependence of arterial stiffness on the levels of transmural
pressure at which they are measured, and given the phenom-
enon of BP tracking throughout age, the marked attenuation
in BP differences after adjustment for current MAPsupine was
largely expected. Increased arterial stiffness is primarily
determined by the properties of the extracellular matrix
(elastin, collagen) and vascular smooth muscular cell func-
tion.1,2,29 These properties are strongly affected by lifelong
BP.4,13 Our longitudinal approach enabled us to pinpoint
adolescence as the period early in life when increases in
predominantly DP, but also in SP pressure, and thus MAP,
may be linked to greater arterial stiffness later in life. The
observation of DP as a major determinant of arterial stiffness
may reflect the phenomenon of “downstream” increase in
resistance at the level of the arterioles, leading to an “up-
stream” increase in transmural pressure, resulting in both
structural and functional disruption of the arterial pressure
load-bearing elastin–collagen network within the media
layer, and thus greater arterial stiffness.4,29 Our data thus also
are consistent with the subtypes of elevated SP and DP or
isolated diastolic hypertension that typically characterize
young adults. Still, with aging, increased arterial stiffness may
affect the BP–arterial stiffness relationship, such that after age
50 to 60 years4 another phenotype becomes more prevalent,
that of isolated systolic hypertension.
Another key finding of the present study was that the levels
of central rather than of total body fatness during adolescence
impacted on arterial stiffness in adulthood. Body fatness,
particularly central fatness, is a well-recognized correlate of
arterial stiffness,5–8 even though the mechanisms linking the
two are incompletely understood.30 The impact of total or
central body fatness on other cardiovascular RF and their
clustering may constitute one such mechanism.30 We have
previously shown in this cohort that increases in total and
central body fatness from adolescence to young adulthood
were critical for the development of the metabolic syndrome
in adulthood,20 which, in turn, was associated with greater
arterial stiffness.23 In the present study, we show longitudi-
nally that the levels of mainly MAP and dyslipidemia and to
a less extent of physical fitness could explain a great part of
the association between total body fatness (up to 60%), but
less so of the association between central body fatness and
arterial stiffness (25% only). This could be appreciated by
the change in the magnitude of the differences in BMI or the
SKF and the SKF ratio after adjustment for those risk
factors (ie, model 3 vs model 2 in Table 2). Other (central)
adiposity-related factors thus also may contribute to arterial
stiffness. These may include adrenergic (sympathetic overac-
tivity) and metabolic (eg, insulin resistance, hypoadi-
ponectinemia, hyperleptinemia, proinflammatory cytokines)
pathobiological mechanisms.30 Measures of these potential
explanatory mechanisms were not assessed throughout the
whole longitudinal period covered in this study, however.
Noteworthy, subjects with stiffer arteries in adulthood were
characterized not only by greater levels of BP and central
fatness extending back to early age, which is supportive of
tracking, but also by steeper increases in BP (mainly DP) and
(central) fatness, particularly during young adulthood, sup-
portive of a “horse-racing” phenomenon surrounding these
risk factors.31 These observations may have important impli-
cations for prevention. Tracking, ie, the stability of rank of an
individual in the RF distribution over time has bearing in the
early detection of subjects at risk in the sense that RF levels
in young adulthood will be good predictors of their levels
later in life.22 Horse-racing suggests that the rate of change of
these RF, in addition to their absolute levels at any given
point in time, may contribute to the identification of subjects
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at risk and likely to benefit from preventive measures, and
thus should be monitored.32 In support of this, in the present
cohort the prevalence of (pre)hypertension or overweight/
obesity during adolescence was very low and, per se, not
predictive of significantly greater carotid stiffness (lowest
versus other tertiles) later in life (OR, 0.85; 95% CI, 0.32–
3.26; and OR, 2.54; 95% CI, 0.67–9.55, respectively). In-
stead, increases in BP and (central) fatness observed between
adolescence and young adulthood, even when occurring
within the range of values below those commonly used as
indicative or risk, seemed to be setting the grounds for greater
arterial stiffness later in life. In this respect, and on the basis
of these RF, our data suggest that subjects with less stiff
carotid arteries were those who, between adolescence and
young adulthood, had relatively lesser increases in SP and DP
(barely exceeding the mean values of 130 and 85 mm Hg,
respectively, at age 36 years), BMI (not exceeding the mean
value of 24 kg/m2 at age 36 years), and SKF ratio 0.57
throughout the adult period (for age-specific references
please see Figure); these values could be used as references
for a healthy profile within the age periods as examined
herein. However, a note of caution is warranted here. The
magnitude of the differences found in our study between
individuals with stiffer vs less stiffness carotid arteries were
small relative to the observed variability in the lifelong levels
of the RF examined. Larger studies are needed to ascertain
with more certainty the limits of such a healthy or desirable
risk profile in young age.
Differences in total-to-HDL cholesterol ratio, triglycerides,
cardiorespiratory fitness, and resting HR between subjects
with stiffer vs less stiff carotid arteries in adulthood were only
visible during adulthood. However, the deleterious impact of
each of these RF on arterial stiffness was, to a great extent,
explained by concomitant trajectories of the other RF, mainly
the increases in BP and (the accentuation of a central pattern
of) body fatness, which actually preceded and thus may have
triggered the former.
There are limitations to the present study that need to be
addressed. First, our findings were confined to subjects in
whom complete data for arterial properties were obtained
during the follow-up examination in the year 2000. However,
levels of BP, total and central fatness, blood lipids, cardiore-
spiratory fitness, and HR in these subjects did not differ, at
any earlier time point, from those subjects who dropped-out
(data not shown); this indicates that selection bias did not
threaten the validity of our findings. Second, the trajectories
of the RF reported herein refer to subjects who were adoles-
cents in the late 1970s. Given the current obesity epidemic in
youth, it is possible that the critical periods identified herein
may have shifted to even earlier ages. From an etiologic point
of view, this does not hinder the validity of our findings; in
fact, it just emphasizes the need for public health interven-
tions targeting young people.26,27 Third, although we have
adjusted our analyses extensively for several potential con-
founders, we cannot fully exclude the possibility of residual
confounding. Fourth, although the use of local pulse pressure
estimated by calibration of the distension waveforms25 in-
stead of brachial pulse pressure for the calculations of the
carotid stiffness estimates constitutes a strength to our study,
this method still may not optimally reflect the level of pulse
pressure at the level of the carotid artery. Finally, given its
observational design, this study cannot prove causality; fur-
thermore, because carotid stiffness levels were measured at
age 36 years only, we cannot rule out the possibility of
reverse causality (eg, that subjects with stiffer arteries at any
earlier time point may have been less prone to adopt healthier
lifestyles, which could lead to better cardiovascular risk
profiles). However, we deemed this less likely because the
young subjects were, throughout the whole longitudinal
period, unaware of and asymptomatic with regard to their
stiffness levels.
Perspectives
Our findings support the existence of multiple and inter-
twined mechanisms in the pathogenesis of arterial stiffness
that have their origins in early life. BP and a central pattern of
body fatness have a pivotal role herein. Efforts to prevent
arterial stiffening and its cardiovascular sequelae thus most
usefully may be targeted at the prevention of increases in BP
and central fatness starting during early age.
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METHODS 
Longitudinal measurements of cardiovascular risk factors 
Blood pressure was measured twice with a sphygmomanometer (Speidl-Keller, Franken & 
Itallie, Amsterdam, The Netherlands) and a standard pressure cuff, after subjects had rested in 
a sitting position for at least 5 min. The lowest value of the systolic (SP) and diastolic blood 
pressure (DP) values thus obtained were recorded and used in the analyses.1 Mean arterial 
pressure (MAP), throughout the longitudinal period, was calculated as [(2*DP)+SP]/3. 
Prevalence of pre-hypertension or hypertension was defined: using sex, age and height-specific 
cut-off values for SP and/or DP according to the Task Force for Blood pressure in Children 
criteria and during adolescence (considered present if exceeding those cut-off values in at least 
3 moments during this period);2 if SP/DP≥130/85 or ≥140/90 during adulthood.3 
Anthropometric measures included standing height, body weight, and biceps, triceps, 
subscapular and suprailiac skinfolds and were performed by trained observers. We calculated, 
as indicators of total body fatness, the body mass index (BMI; in kg/m2) and the sum of the 
thickness of the four skinfolds (ΣSKF, in mm); the ratio of the subscapular + suprailiac 
skinfolds to the ΣSKF (SKF ratio) was used as an estimate of central fat distribution.1,4-7 
Prevalence of overweight or obesity was defined using age and sex-specific cut-off values for 
BMI according to the International Obesity Task Force criteria during adolescence, and as 
BMI≥25 or ≥30 kg/m2, respectively, during adulthood.8 
 Total and HDL-cholesterol and triglycerides, the latter from the age of 21 onwards 
only, were measured in non-fasting blood samples (10 mL) drawn from the antecubital vein 
with the use of enzymatic techniques (Roche Diagnostics, Mannheim, Germany); throughout 
the years, external quality control of these measures took place with target samples from a 
World Health Organization reference laboratory.1,9,10  
Throughout the years cardiorespiratory fitness was measured in the same laboratory 
with the same protocol and equipment: a maximal running test on a treadmill (Quinton, Bothel, 
Washington, USA, model 18-54) with direct measurements of oxygen uptake (Ergoanalyzer, 
Jager, Bunnik, The Netherlands). Subjects were instructed to run at a constant speed of 8 km/h 
while the slope of the treadmill increased every 2 minutes in a stepwise fashion, and were 
encouraged to continue running to their maximum. Maximal oxygen uptake (VO2max) 
expressed by kg of fat-free mass (i.e. mL/min/kgFFM) was used in the analyses as a measure of 
cardiorespiratory fitness.11 FFM was derived by subtracting fat mass, which was calculated 
from skinfold thickness according to age and sex-specific equations 12,13 from total body 
weight. Resting heart rate (HR) was measured telemetrically (Telecust 36 and Sirecust BS1, 
Siemens, Amsterdam, The Netherlands) as the mean value from 15 R-R intervals in the last 15 
seconds of the minute, after subjects had been sitting on a chair for 5 minutes. 
Information on habitual physical activity levels, total energy intake, alcohol 
consumption and smoking behavior were assessed by means of interviews and 
questionnaires.14-16 
 
Arterial stiffness 
Briefly, all subjects had abstained from smoking and caffeine-containing beverages on the day 
the measurements were performed. Measurements took place after subjects had been resting in 
a supine position for 15 min in a quiet temperature-controlled room. Properties of the right 
common carotid artery (10 mm proximal to the beginning of the bulb) were obtained by two 
trained vascular sonographers with the use of an ultrasound scanner equipped with a 7.5-MHz 
linear array probe (Pie Medical, Maastricht, The Netherlands). The ultrasound scanner was 
connected to a personal computer equipped with an acquisition system and a vessel wall 
movement detector software system (Wall Track System 2, Pie Medical, Maastricht, The 
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Netherlands). This integrated device enabled measurements of arterial diameter (D), distension 
(∆D), and intima-media thickness (IMT) as described in detail elsewhere.17   
Throughout the entire period of ultrasound imaging, systolic (SP), diastolic (DP) and 
mean arterial pressure (MAPsupine) were assessed in the left arm at 5 minutes intervals with an 
oscillometric device (Colin Press-Mate, model BP-8800, Komaki-City, Japan). Brachial artery 
pulse pressure (PP) was defined SP – DP, and PP at the level of the common carotid artery was 
calculated by calibration of the diameter distension waveforms obtained at the brachial and 
carotid arteries.18 The mean D, ∆D, IMT and local PP of 3 consecutive measurements (each 
including 3 to 7 heart beats) were used to estimate the carotid distensibility (DC) and 
compliance (CC) coefficients, and the Young’s elastic modulus (YEM) as follows:4,5,17 
DC=(2∆D·D+∆D2)/(PP·D2)   in 10-3/kPa 
CC=π·(2D·∆D+∆D2)/4PP    in mm2/kPa 
YEM=D/(IMT·DC)    in 103·kPa  
 
 
REFERENCES 
 
1.  van Lenthe FJ, van Mechelen W, Kemper HC, Twisk JW. Association of a central pattern of body fat 
with blood pressure and lipoproteins from adolescence into adulthood. The Amsterdam Growth and 
Health Study. Am J Epidemiol. 1998;147:686-693. 
2.  National High Blood Pressure Education Program Working Group on High Blood Pressure in 
Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood 
pressure in children and adolescents. Pediatrics. 2004;114:555–576. 
3.  Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, 
Oparil S, Wright JT Jr, Rocella EJ, and the National High Blood Pressure Education Program 
Coordinating Committee. Seventh report of the Joint  National Committee on Prevention, Detection, 
Evaluation, and Treatment of High Blood Pressure. Hypertension; 2003;42;1206-1252. 
4. Ferreira I, Henry RM, Twisk JW, van Mechelen W, Kemper HC, Stehouwer CD. The metabolic 
syndrome, cardiopulmonary fitness, and subcutaneous trunk fat as independent determinants of 
arterial stiffness: the Amsterdam Growth and Health Longitudinal Study. Arch Intern Med.  
2005;165:875-882. 
5. Ferreira I, Twisk JW, van Mechelen W, Kemper HC, Seidell JC, Stehouwer CD. Current and 
adolescent body fatness and fat distribution: relationships with carotid intima-media thickness and 
large artery stiffness at the age of 36 years. J Hypertens. 2004;22:145-155. 
6.  Nooyens AC, Koppes LL, Visscher TL, Twisk JW, Kemper HC, Schuit AJ, van Mechelen W, Seidell 
JC. Adolescent skinfold thickness is a better predictor of high body fatness in adults than is body 
mass index: the Amsterdam Growth and Health Longitudinal Study. Am J Clin Nutr. 2007;85:1533-
1539. 
7.  van Lenthe FJ, Kemper HC, van Mechelen W, Twisk JW. Development and tracking of central 
patterns of subcutaneous fat in adolescence and adulthood: the Amsterdam Growth and Health 
Study. Int J Epidemiol.  1996;25:1162-1171. 
8.  Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight 
and obesity worldwide: international survey. BMJ. 2000;320:1240-1243. 
9.  Twisk JW, Kemper HC, Mellenbergh GJ. Longitudinal development of lipoprotein levels in males and 
females aged 12-28 years: the Amsterdam Growth and Health Study. Int J Epidemiol. 1995;24:69-77. 
10.  Twisk JW, Kemper HC, van Mechelen W, Post GB. Tracking of risk factors for coronary heart 
disease over a 14-year period: a comparison between lifestyle and biologic risk factors with data from 
the Amsterdam Growth and Health Study. Am J Epidemiol. 1997;145:888-898. 
 4 
11.  Kemper HC, Twisk JW, Koppes LL, van Mechelen W, Post GB. A 15-year physical activity pattern is 
positively related to aerobic fitness in young males and females (13-27 years). Eur J Appl Physiol. 
2001;84:395-402. 
12.  Durnin JV, Rahaman MM. The assessment of the amount of fat in the human body from 
measurements of skinfold thickness. Br J Nutr. 1967;21:681-689. 
13.  Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold 
thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr. 1974;32:77-
97. 
14. van Mechelen W, Twisk JW, Post GB, Snel J, Kemper HC. Physical activity of young people: the 
Amsterdam Longitudinal Growth and Health Study. Med Sci Sports Exerc.  2000;32:1610-1616. 
15. Kemper HC. Amsterdam Growth and Health Longitudinal study (AGAHLS). A 23-year follow-up from 
teenager to adult about lifestyle and health. Basel, Switzerland: Karger; 2004. 
16. Ferreira I, Twisk JW, van Mechelen W, Kemper HC, Stehouwer CD. Development of fatness, fitness, 
and lifestyle from adolescence to the age of 36 years: determinants of the metabolic syndrome in 
young adults: the Amsterdam Growth and Health Longitudinal Study. Arch Intern Med.  2005;165:42-
48.  
17. Brands PJ, Hoeks AP, Willigers J, Willekes C, Reneman RS. An integrated system for the non-
invasive assessment of vessel wall and hemodynamic properties of large arteries by means of 
ultrasound. Eur J Ultrasound. 1999;9:257-266. 
18. Van Bortel LM, Balkestein EJ, van der Heijden-Spek JJ, Vanmolkot FH, Staessen JA, Kragten JA, 
Vredeveld JW, Safar ME, Struijker Boudier HA, Hoeks AP. Non-invasive assessment of local arterial 
pulse pressure: comparison of applanation tonometry and echo-tracking. J Hypertens. 2001;19:1037-
1044. 
 5 
Table S1. Mean differences in blood pressure and body fatness, throughout the 24-year longitudinal period, between subjects with stiffer vs. less stiff 
carotid arteries at the age of 36, as defined on the basis the carotid DC, CC or YEM.  
 Mean arterial pressure (mmHg)  Systolic pressure (mmHg)  Diastolic pressure (mmHg) 
Model 
T1 vs. T3 
DC 
 
T1 vs. T3 
CC 
 
T3 vs. T1 
YEM 
 
T1 vs. T3 
DC 
 
T1 vs. T3 
CC 
 
T3 vs. T1 
YEM 
 
T1 vs. T3 
DC 
 
T1 vs. T3 
CC  
T3 vs. T1 
YEM 
β 95% CI  β 95% CI  β 95% CI  β 95% CI  β 95% CI  β 95% CI  β 95% CI  β 95% CI β 95% CI 
1 5.3‡ 3.9; 6.8  4.2‡ 2.7; 5.7  4.3‡ 2.8; 5.9  4.7‡ 2.6; 6.8  4.3‡ 2.2; 6.4  3.6† 1.5; 5.8  5.7‡ 4.3; 7.1  4.2‡ 2.7; 5.6  4.7‡ 3.2; 6.2 
2 5.2‡ 3.7; 6.6  4.0‡ 2.5; 5.5  4.1‡ 2.6; 5.6  4.5‡ 2.4; 6.6  4.1‡ 2.0; 6.2  3.4† 1.3; 5.6  5.5‡ 4.1; 6.9  4.0‡ 2.5; 5.5  4.4‡ 3.0; 5.9 
3a - -  - -  - -  - -  - -  - -  - -  - -  - - 
3b 4.6‡ 3.1; 6.0  3.5‡ 2.0; 5.0  3.6‡ 2.1; 5.2  3.7† 1.6; 5.8  3.4† 1.3; 5.5  2.8† 0.7; 5.0  5.0‡ 3.6; 6.5  3.6‡ 2.1; 5.0  4.1‡ 2.6; 5.6 
3c 4.7‡ 3.2; 6.1  3.7‡ 2.2; 5.1  3.8‡ 2.2; 5.3  4.0‡ 1.9; 6.1  3.7† 1.6; 5.8  3.1† 1.0; 5.3  5.1‡ 3.7; 6.4  3.7‡ 2.2; 5.1  4.1‡ 2.6; 5.6 
3d 5.1‡ 3.7; 6.6  4.0‡ 2.5; 5.5  4.1‡ 2.6; 5.6  4.5‡ 2.4; 6.5  4.1‡ 2.0; 6.2  3.4† 1.0; 5.3  5.5‡ 4.1; 6.8  4.0‡ 2.5; 5.5  4.5‡ 3.0; 5.9 
3e 4.9‡ 3.5; 6.3  3.6‡ 2.2; 5.1  3.9‡ 2.4; 5.4  4.1‡ 2.1; 6.2  3.5‡ 1.5; 5.6  3.2† 1.0; 5.3  5.3‡ 3.9; 6.6  3.7‡ 2.2; 5.1  4.3‡ 2.8; 5.7 
3 4.1‡ 2.6; 5.5  3.0‡ 1.5; 4.5  3.3‡ 1.8; 4.9  3.0† 0.9; 5.1  2.7† 0.6; 4.7  2.4* 0.3; 4.5  4.6‡ 3.2; 6.0  3.2‡ 1.7; 4.7  3.8‡ 2.3; 5.3 
4 1.7* 0.3; 3.1  1.3 -0.3; 2.7  1.3 -0.1; 2.7  0.0 -2.2; 2.2  0.6 -1.4; 2.7  0.4 0.3; 0.5  2.6‡ 1.2; 3.9  1.7* 0.4; 3.1  2.0† 0.6; 3.5 
 Body mass index (kg/m2)  Sum of 4 skinfolds (mm)  Skinfolds ratio (*10) 
Model 
T1 vs. T3   
DC 
 
T1 vs. T3 
CC 
 
T3 vs. T1  
YEM 
 T1 vs. T3  
DC 
 
T1 vs. T3  
CC 
 
T3 vs. T1  
YEM 
 T1 vs. T3  
DC 
 
T1 vs. T3  
CC  
T3 vs. T1  
YEM 
β 95% CI  β 95% CI  β 95% CI  β 95% CI  β 95% CI  β 95% CI  β 95% CI  β 95% CI β 95% CI 
1 1.06‡ 0.47; 1.65  0.69* 0.12; 1.25  0.98* 0.15; 1.24  6.1‡ 2.9; 9.4  3.7† 0.8; 6.7  5.8‡ 2.7; 8.9  0.36‡ 0.22; 0.51  0.31‡ 0.16; 0.46  0.26‡ 0.11; 0.40 
2 1.08† 0.46; 1.70  0.71* 0.12; 1.30  1.00† 0.40; 1.58  6.2‡ 2.9; 9.6  3.8† 0.7; 6.8  5.7‡ 2.6; 8.9  0.34‡ 0.20; 0.49  0.29‡ 0.14; 0.44  0.24† 0.10; 0.38 
 6 
3a 0.70* 0.10; 1.30  0.41 -0.15; 0.97  0.69* 0.13; 1.25  3.9* 0.7; 7.2  2.0 -1.0; 4.9  3.9* 0.8; 7.0  0.28‡ 0.14; 0.43  0.25‡ 0.10; 0.40  0.20† 0.05; 0.34 
3b - -  - -  - -  - -  - -  - -  - -  - -  - - 
3c 0.77* 0.18; 1.36  0.51 -0.05; 1.08  0.76† 0.21; 1.31  4.3† 1.1; 7.5  2.5 -0.4; 5.4  4.2† 1.2; 7.2  0.27‡ 0.14; 0.41  0.25‡ 0.11; 0.40  0.20† 0.06; 0.33 
3d 1.02† 0.41; 1.63  0.67* 0.08; 1.26  0.96† 0.37; 1.54  5.9† 2.6; 9.2  3.6† 0.5; 6.6  5.6‡ 2.5; 8.8  0.34‡ 0.20; 0.48  0.30‡ 0.15; 0.45  0.24† 0.10; 0.38 
3e 1.05† 0.43; 1.67  0.67* 0.08; 1.26  0.96† 0.39; 1.56  5.8† 2.5; 9.1  3.2* 0.2; 6.2  5.5† 2.4; 8.5  0.34‡ 0.20; 0.49  0.30‡ 0.15; 0.45  0.24† 0.10; 0.39 
3 0.46 -0.11; 1.03  0.41 -0.09; 0.91  0.51 -0.02; 1.04  2.4 -0.7; 5.5  1.0 -1.9; 3.8  2.8 -0.2; 5.7  0.25‡ 0.11; 0.38  0.24‡ 0.10; 0.39  0.16* 0.03; 0.30 
4 0.19 -0.42; 0.80  0.05 -0.25; 0.36  0.28 -0.27; 0.83  1.1 -2.1; 4.2  -1.3 -3.2; 0.5  1.6 -1.4; 4.7  0.29‡ 0.15; 0.43  0.19† 0.08; 0.30  0.18† 0.04; 0.32 
Model 1: adjusted for sex, height and time;  
Model 2: model 1 + lifestyle variables (i.e., total energy intake, physical activity level, smoking and alcohol consumption status); 
Model 3a: model 2 + MAP; Model 3b: model 2 + skinfolds ratio; Model 3c: model 2 + total-to-HDL cholesterol ratio; model 3d: model 2 + VO2max; Model 3e: model 2 + 
resting heart rate;  
Model 3: model 2 + all risk factors in models 3a-e; 
Model 4: model 3 + current MAPsupine. 
*p<0.05; †p<0.01; ‡p<0.001.  
Note: columns shaded in grey show data also shown in Table 2 of printed manuscript and are also shown here to enable direct comparison across stiffness estimates.
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Table S2. Mean differences in blood lipids and physical fitness, throughout the 24-year longitudinal period, between 
subjects with stiffer vs. less stiff carotid arteries at the age of 36, as defined on the basis the carotid DC, CC or YEM.  
 Total-to-HDL cholesterol ratio  Triglycerides|| 
Model 
T1 vs. T3 
DC  
T1 vs. T3 
CC  
T3 vs. T1 
YEM  
T1 vs. T3 
DC  
T1 vs. T3 
CC  
T3 vs. T1 
YEM 
β 95% CI  β 95% CI  β 95% CI  β 95% CI  β 95% CI  β 95% CI 
1 0.37† 0.15; 0.58  0.23* 0.04; 0.43  0.27* 0.06; 0.48  1.18† 1.07; 1.30  1.12* 1.01; 1.23  1.13* 1.03; 1.24 
2 0.34† 0.13; 0.55  0.22* 0.03; 0.42  0.24* 0.03; 0.44  1.19‡ 1.08; 1.30  1.12* 1.01; 1.23  1.14† 1.03; 1.25 
3a 0.25* 0.04; 0.46  0.15 -0.04; 0.34  0.16 -0.04; 0.37  1.13* 1.03; 1.24  1.09 0.99; 1.21  1.09 1.00; 1.20 
3b 0.20 -0.00; 0.40  0.11 -0.08; 0.30  0.14 -0.06; 0.34  1.14† 1.04; 1.25  1.12* 1.01; 1.23  1.10* 1.00; 1.20 
3c - -  - -  - -  - -  - -  - - 
3d 0.32† 0.11; 0.53  0.20* 0.01; 0.41  0.24* 0.03; 0.45  1.16† 1.05; 1.27  1.09 0.98; 1.20  1.11* 1.01; 1.22 
3e 0.32† 0.11; 0.53  0.20* 0.01; 0.41  0.22* 0.01; 0.43  1.16† 1.05; 1.27  1.09 0.99; 1.21  1.12* 1.02; 1.23 
3 0.11 -0.09; 0.31  0.10 -0.10; 0.29  0.09 -0.11; 0.28  1.05 0.96; 1.15  1.02 0.94; 1.12  1.02 0.94; 1.12 
4 0.09 -0.12; 0.29  0.06 -0.13; 0.26  0.06 -0.13; 0.26  1.02 0.93; 1.12  1.00 0.91; 1.10  1.00 0.91; 1.10 
 
VO2max  
(mL/min per kgFFM) 
 Resting heart rate  
(bpm) 
Model 
T1 vs. T3   
DC  
T1 vs. T3 
CC  
T3 vs. T1  
YEM 
 T1 vs. T3  
DC  
T1 vs. T3  
CC  
T3 vs. T1  
YEM 
β 95% CI  β 95% CI  β 95% CI  β 95% CI  β 95% CI  β 95% CI 
1 -1.39* -2.58; -0.19  -1.19* -2.68; -0.09  -0.64 -1.84; 0.56  4.7‡ 2.3; 7.1  6.0‡ 3.7; 8.3  3.2† 1.0; 5.5 
2 -1.28* -2.44; -0.13  -1.21* -2.35; -0.07  -0.50 -1.66; 0.66  4.2† 1.8; 6.6  5.6‡ 3.3; 8.0  2.7* 0.5; 5.0 
3a -1.26* -2.42; -0.10  -1.20* -2.34; -0.05  -0.46 -1.62; 0.70  3.4† 1.0; 5.7  5.0‡ 2.7; 7.3  2.0 -0.2; 4.3 
3b -1.45* -2.61; -0.29  -1.27* -2.48; -0.07  -0.60 -1.76; 0.56  4.2† 1.8; 6.6  5.6‡ 3.3; 8.0  2.7* 0.4; 5.0 
3c -1.01 -2.17; 0.14  -0.98 -2.20; 0.24  -0.32 -1.49; 0.85  3.8† 1.3; 6.2  5.4‡ 3.0; 7.7  2.3* 0.1; 4.6 
3d - -  - -  - -  3.8† 1.4; 6.1  5.3‡ 3.0; 7.6  2.5* 0.3; 4.7 
3e -0.96 -2.09; 0.17  -0.93 -2.06; 0.20  -0.28 -1.43; 0.86  - -  - -  - - 
3 -1.03 -2.17; -0.11  -0.83 -2.03; 0.37  -0.34 -1.51; 0.83  2.9* 0.5; 5.2  4.7‡ 2.5; 7.0  1.7 -0.5; 3.9 
4 -0.74 -1.98; 0.51  -0.66 -1.80; 0.49  -0.04 -1.27; 1.20  2.3 -0.2; 4.9  4.4‡ 2.1; 6.7  1.0 -1.3; 3.4 
Model 1: adjusted for sex, height and time;  
Model 2: model 1 + lifestyle variables (i.e., total energy intake, physical activity level, smoking and alcohol 
consumption status); 
Model 3a: model 2 + MAP; Model 3b: model 2 + skinfolds ratio; Model 3c: model 2 + total-to-HDL cholesterol ratio; 
model 3d: model 2 + VO2max; Model 3e: model 2 + resting heart rate;  
Model 3: model 2 + all risk factors in models 3a-e; 
Model 4: model 3 + current MAPsupine. 
*p<0.05; †p<0.01; ‡p<0.001.  
Note: columns shaded in grey show data that are also described in text of printed manuscript and are also shown 
here to enable direct comparison across stiffness estimates.  
